Lotus Pharmaceutical Co., Ltd. (“Lotus” or “the Company”, Taiwan TWSE ticker: 1795) today announced that its Board of Directors resolved to declare cash dividends of NT$0.35 per share out of FY2020 distributable profits.
This is not only the first time Lotus is able to paying dividend since the joint-force with Alvogen in 2014, after offsetting all the accumulated deficits by the record profits in 2020, but also the highest dividends Lotus has ever paid during the past 15 years.
Robert Wessman, Chairman of Lotus, commented: “We are very excited that we are finally able to share with our shareholders the fruit of our endeavor after six long years. Since Lotus’ strategic alliance with Alvogen, we have made significant investments in all areas of the business. We have succeeded to transform the Company from a single market local company to a global player. Thanks to dedication and support of our employees, customers, suppliers, and shareholders, Lotus has delivered the best year yet in a turbulent environment and became the largest Taiwanese pharmaceutical company by revenue in 2020. Maybe the first dividend payout is not large, but it marks a significant milestone in our quest to build a global pharmaceutical company out of a small island nation of Taiwan. we are confident that Lotus will be sharing our success not only this year but also consistently going forward.”